Neuphoria Therapeutics Inc. - NEUP
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$6.689M
QoQ value delta ($000)
+$1.01M
(+17.78%)
Implied price effect (QoQ)
+4.86%
Shares
Total shares
1,646,705
QoQ shares delta
+180,706
(+12.33%)
Total shares held by funds (by quarter)
Market chart (NEUP)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 17 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Lynx1 Capital Management LP | 3,562 | 875,328 | 0.56% |
| AdvisorShares Investments LLC | 632 | 155,367 | 0.12% |
| Shay Capital LLC | 614 | 151,010 | 0.05% |
| BALYASNY ASSET MANAGEMENT L.P. | 578 | 142,183 | 0.0% |
| Squadron Capital Management LLC | 312 | 76,728 | 0.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 211 | 52,007 | 0.0% |
| Ikarian Capital, LLC | 193 | 47,443 | 0.02% |
| ADAR1 Capital Management, LLC | 122 | 30,000 | 0.01% |
| FNY Investment Advisers, LLC | 107 | 26,500 | 0.05% |
| VANGUARD GROUP INC | 81 | 20,950 | 0.0% |
| CITADEL ADVISORS LLC | 78 | 19,331 | 0.0% |
| BOOTHBAY FUND MANAGEMENT, LLC | 56 | 14,000 | 0.0% |
| Virtu Financial LLC | 49 | 12,033 | 0.0% |
| COMMONWEALTH EQUITY SERVICES, LLC | 45 | 11,222 | 0.0% |
| Merck & Co., Inc. | 40 | 10,027 | 0.01% |
| UBS Group AG | 9 | 2,316 | 0.0% |
| MORGAN STANLEY | 0 | 58 | 0.0% |
| RHUMBLINE ADVISERS | 0 | 202 | 0.0% |